Klingman & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-918
Closed -$71K – 132
2016
Q3
$71K Hold
918
– – 0.02% 162
2016
Q2
$72K Hold
918
– – 0.02% 163
2016
Q1
$75K Hold
918
– – 0.03% 161
2015
Q4
$82K Sell
918
-3,800
-81% -$323K 0.03% 177
2015
Q3
$362K Buy
4,718
+3,800
+414% +$318K 0.14% 75
2015
Q2
$77K Hold
918
– – 0.03% 153
2015
Q1
$83K Hold
918
– – 0.03% 142
2014
Q4
$74K Buy
+918
New +$72.5K 0.03% 150

Other funds holding CAH

Klingman & Associates's CAH Position: Q4 2016 in Review

Klingman & Associates sold out of Cardinal Health (CAH) in Q4 2016, closing a stake of 918 shares — an estimated $71K sold.

Klingman & Associates first reported a position in CAH in Q4 2014 and held it in 8 quarters. The position peaked at $362K in Q3 2015. 773 funds tracked by Wall St. Rank hold CAH as of Q4 2016.

  • Klingman & Associates reported no remaining Cardinal Health position as of Q4 2016 after selling out during the quarter.
  • Klingman & Associates sold 918 Cardinal Health shares in Q4 2016, an estimated $71K.
  • Klingman & Associates first reported a position in Cardinal Health in Q4 2014 and held it in 8 quarters.
  • Klingman & Associates's Cardinal Health position peaked at $362K in Q3 2015.
  • 773 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.